Boston Scientific (BSX) Earnings Date, Estimates & Call Transcripts $90.00 -1.50 (-1.64%) (As of 11/22/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Boston Scientific Latest Earnings SummaryUpcoming Q4 Earnings DateJan. 29EstimatedActual EPS (Oct. 23) $0.63 Beat By $0.04 Consensus EPS (Oct. 23) $0.59 Boston Scientific posted Q3 2024 earnings on October 23, 2024, reporting an EPS of $0.63, which topped analysts' consensus estimates of $0.59 by $0.04. Quarterly revenue rose 19.3% year-over-year to $4.21 billion, above analyst estimates of $4.04 billion. With a trailing EPS of $1.21 and a P/E Ratio of 74.38, Boston Scientific's earnings are expected to grow 10.57% next year, from $2.46 to $2.72 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckBSX Upcoming EarningsBoston Scientific's next earnings date is estimated for Wednesday, January 29, 2025, based off prior year's reporting schedules. Get Boston Scientific Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Boston Scientific and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBSX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BSX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Boston Scientific Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.52$0.52$0.520.500 - 0.520Q2 20241$0.56$0.56$0.560.570 - 0.590Q3 20241$0.54$0.54$0.540.570 - 0.590Q4 20241$0.58$0.58$0.580.640 - 0.660FY 20244$2.20$2.20$2.20 Q1 20251$0.63$0.63$0.63 Q2 20251$0.61$0.61$0.61 Q3 20251$0.62$0.62$0.62 Boston Scientific Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 1/29/2025(Estimated)------- 10/23/2024Q3 2024$0.59$0.63+$0.04$0.94$4.04B$4.21B 7/24/2024Q2 2024$0.58$0.62+$0.04$1.02$4.02B$4.12B 4/24/2024Q1 2024$0.51$0.56+$0.05$0.79$3.68B$3.86B 1/31/2024Q4 2023$0.51$0.55+$0.04$0.76$3.59B$3.73B 10/26/2023Q3 2023$0.48$0.50+$0.02$0.66$3.48B$3.53B 7/27/2023Q2 2023$0.49$0.53+$0.04$0.88$3.50B$3.60B This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here4/26/2023Q1 2023$0.43$0.47+$0.04$0.73$3.16B$3.39B 2/1/2023Q4 2022$0.47$0.45 -$0.02$0.81$3.24B$3.24B Boston Scientific Earnings - Frequently Asked Questions When is Boston Scientific's earnings date? Boston Scientific has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates. Learn more on BSX's earnings history. What guidance has Boston Scientific issued on next quarter's earnings? Boston Scientific issued an update on its fourth quarter earnings guidance on Wednesday, October, 23rd. The company provided earnings per share guidance of $0.64-$0.66 for the period, compared to the consensus EPS estimate of $0.64. The company issued revenue guidance of $4.34-$4.41 billion, compared to the consensus revenue estimate of $4.28 billion. Did Boston Scientific beat their earnings estimates last quarter? In the previous quarter, Boston Scientific (NYSE:BSX) reported $0.63 earnings per share (EPS) to beat the analysts' consensus estimate of $0.59 by $0.04. Learn more on analysts' earnings estimate vs. BSX's actual earnings. How can I listen to Boston Scientific's earnings conference call? The conference call for Boston Scientific's latest earnings report can be listened to online. Listen to Conference Call How can I read Boston Scientific's conference call transcript? The conference call transcript for Boston Scientific's latest earnings report can be read online. Read Transcript How much revenue does Boston Scientific generate each year? Boston Scientific (NYSE:BSX) has a recorded annual revenue of $14.24 billion. How much profit does Boston Scientific generate each year? Boston Scientific (NYSE:BSX) has a recorded net income of $1.59 billion. BSX has generated $1.21 earnings per share over the last four quarters. What is Boston Scientific's price-to-earnings ratio? Boston Scientific (NYSE:BSX) has a trailing price-to-earnings ratio of 74.38 and a forward price-to-earnings ratio of 36.59. The price/earnings-to-growth ratio is 2.69. What is Boston Scientific's EPS forecast for next year? Boston Scientific's earnings are expected to grow from $2.46 per share to $2.72 per share in the next year, which is a 10.57% increase. ` More Earnings Resources from MarketBeat Related Companies ABT Earnings Results ISRG Earnings Results SYK Earnings Results MDT Earnings Results BDX Earnings Results EW Earnings Results RMD Earnings Results IDXX Earnings Results DXCM Earnings Results STE Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report A “Thank You Gift” From Pres. Trump - Genius (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide This page (NYSE:BSX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could...Investors Alley | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
